Necitumumab
Product Specifications
CAS Number
906805-06-9
Target
EGFR
Related Pathways
Tyrosine Kinase/Adaptors, JAK/STAT signaling, Angiogenesis
Purity
0.991
Bioactivity
Necitumumab (IMC-11F8) is a human monoclonal antibody directed against the epidermal growth factor (EGF) receptor, an anti-angiogenic agent used in the treatment of advanced non-small cell lung cancer, and may be used in cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NB57391-01 25 mg
4- (1-Benzylpiperidin-4-Ylamino) -2- (Methylthio) Pyrimidine-5-Carboxylic Acid
Sign In for Pricing
View Details NB57391-02 50 mg
4- (1-Benzylpiperidin-4-Ylamino) -2- (Methylthio) Pyrimidine-5-Carboxylic Acid
Sign In for Pricing
View Details NB57391-03 100 mg
4- (1-Benzylpiperidin-4-Ylamino) -2- (Methylthio) Pyrimidine-5-Carboxylic Acid
Sign In for Pricing
View Details NB57391-04 250 mg
4- (1-Benzylpiperidin-4-Ylamino) -2- (Methylthio) Pyrimidine-5-Carboxylic Acid
Sign In for Pricing
View Details NB57391-05 500 mg
4- (1-Benzylpiperidin-4-Ylamino) -2- (Methylthio) Pyrimidine-5-Carboxylic Acid
Sign In for Pricing
View Details 